Harnessing Gut Microbes for Mental Health: Getting From Here to There

Biological Psychiatry

Volumn 83, Issue 3, 2018, Pages 214-223

  Bruce Keller, Annadora J ^a   Salbaum, J Michael ^a   Berthoud, Hans Rudolf ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Depression; Gut dysbiosis; Gut brain axis; Mental health; Microbiota transplant; Probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

DIET; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; MENTAL HEALTH; MICROBIAL METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VAGUS NERVE; ANIMAL; BRAIN; IMMUNOLOGY; MENTAL DISEASE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; GASTROINTESTINAL MICROBIOME; HUMANS; MENTAL DISORDERS;

EID: 85030843335     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2017.08.014     Document Type: Review

References (166)

1. Lloyd-Price, J., Abu-Ali, G., Huttenhower, C., The healthy human microbiome. Genome Med, 8, 2016, 5.
2. Robles Alonso, V., Guarner, F., Linking the gut microbiota to human health. Br J Nutr 109:Suppl 2 (2013), S21–S26.
3. Collins, S.M., Kassam, Z., Bercik, P., The adoptive transfer of behavioral phenotype via the intestinal microbiota: Experimental evidence and clinical implications. Curr Opin Microbiol 16 (2013), 240–245.
4. Jarchum, I., Pamer, E.G., Regulation of innate and adaptive immunity by the commensal microbiota. Curr Opin Immunol 23 (2011), 353–360.
5. Douglas-Escobar, M., Elliott, E., Neu, J., Effect of intestinal microbial ecology on the developing brain. JAMA Pediatr 167 (2013), 374–379.
6. Bruce-Keller, A.J., Salbaum, J.M., Luo, M., Blanchard, E.T., Taylor, C.M., Welsh, D.A., et al. Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity. Biol Psychiatry 77 (2015), 607–615.
7. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108 (2011), 3047–3052.
8. Aziz, Q., Doré J., Emmanuel, A., Guarner, F., Quigley, E.M., Gut microbiota and gastrointestinal health: Current concepts and future directions. Neurogastroenterol Motil 25 (2013), 4–15.
9. Schwabe, R.F., Jobin, C., The microbiome and cancer. Nat Rev Cancer 13 (2013), 800–812.
10. Drossman, D.A., Hasler, W.L., Rome IV-functional GI disorders: Disorders of gut-brain interaction. Gastroenterology 160 (2016), 1257–1261.
11. Jumpstart Consortium Human Microbiome Project Data Generation Working Group. Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One, 7, 2012, e39315.
12. Zhang, F., Luo, W., Shi, Y., Fan, Z., Ji, G., Should we standardize the 1,700-year-old fecal microbiota transplantation?. Am J Gastroenterol, 107, 2012, 1755.
13. Metchnikoff, E., The Prolongation of Life. Optimistic Studies. 1908, GP Putnam's Sons, New York.
14. ENCODE Project Consortium, Birney, E., Stamatoyannopoulos, J.A., Dutta, A., Guigo, R., Gingeras, T.R., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (2007), 799–816.
15. Bruce-Keller, A.J., Keller, J.N., Morrison, C.D., Obesity and vulnerability of the CNS. Biochim Biophys Acta 1792 (2009), 395–400.
16. Sestan-Pesa, M., Horvath, T.L., Metabolism and mental illness. Trends Mol Med 22 (2016), 174–183.
17. Craft, S., Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment. Curr Alzheimer Res 4 (2007), 147–152.
18. Martin-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., Maes, M., Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr 21 (2016), 184–198.
19. Moloney, R.D., Desbonnet, L., Clarke, G., Dinan, T.G., Cryan, J.F., The microbiome: Stress, health and disease. Mamm Genome 25 (2014), 49–74.
20. Flowers, S.A., Ellingrod, V.L., The microbiome in mental health: Potential contribution of gut microbiota in disease and pharmacotherapy management. Pharmacotherapy 35 (2015), 910–916.
21. Bauer, P.V., Hamr, S.C., Duca, F.A., Regulation of energy balance by a gut-brain axis and involvement of the gut microbiota. Cell Mol Life Sci 73 (2016), 737–755.
22. Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., Gordon, J.I., Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102 (2005), 11070–11075.
23. Zhang, H., DiBaise, J.K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106 (2009), 2365–2370.
24. Kim, K.A., Gu, W., Lee, I.A., Joh, E.H., Kim, D.H., High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One, 7, 2012, e47713.
25. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
26. Tillisch, K., The effects of gut microbiota on CNS function in humans. Gut Microbes 5 (2014), 404–410.
27. Dinan, T.G., Quigley, E.M., Probiotics in the treatment of depression: Science or science fiction?. Psychiatry 45 (2011), 1023–1025.
28. Sudo, N., Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558:Pt 1 (2004), 263–275.
29. Desbonnet, L., Clarke, G., Shanahan, F., Dinan, T.G., Cryan, J.F., Microbiota is essential for social development in the mouse. Mol Psychiatry 19 (2014), 146–148.
30. Jacome, L.F., Burket, J.A., Herndon, A.L., Deutsch, S.I., Genetically inbred Balb/c mice differ from outbred Swiss Webster mice on discrete measures of sociability: relevance to a genetic mouse model of autism spectrum disorders. Autism Res 4 (2011), 393–400.
31. Brinks, V., van der Mark, M., de Kloet, R., Oitzl, M., Emotion and cognition in high and low stress sensitive mouse strains: A combined neuroendocrine and behavioral study in BALB/c and C57BL/6J mice. Front Behav Neurosci, 1, 2007, 8.
32. Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141 (2011), 599–609.
33. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558 (2004), 263–275.
34. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108 (2011), 16050–16055.
35. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
36. Smith, C.J., Emge, J.R., Berzins, K., Lung, L., Khamishon, R., Shah, P., et al. Probiotics normalize the gut-brain-microbiota axis in immunodeficient mice. Am J Physiol Gastrointest Liver Physiol 307 (2014), G793–G802.
37. Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., et al. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol Motil 26 (2014), 510–520.
38. Funkhouser, L.J., Bordenstein, S.R., Mom knows best: The universality of maternal microbial transmission. PLoS Biol, 11, 2013, e1001631.
39. Asnicar, F., Manara, S., Zolfo, M., Truong, D.T., Scholz, M., Armanini, F., et al. Studying vertical microbiome transmission from mothers to infants by strain-level metagenomic profiling. mSystems, 2(1), 2017.
40. Aagaard, K., Stewart, C.J., Chu, D., Una destinatio, viae diversae: Does exposure to the vaginal microbiota confer health benefits to the infant, and does lack of exposure confer disease risk?. EMBO Rep 17 (2016), 1679–1684.
41. Goyal, M.S., Venkatesh, S., Milbrandt, J., Gordon, J.I., Raichle, M.E., Feeding the brain and nurturing the mind: Linking nutrition and the gut microbiota to brain development. Proc Natl Acad Sci U S A 112 (2015), 14105–14112.
42. Rivera, H.M., Christiansen, K.J., Sullivan, E.L., The role of maternal obesity in the risk of neuropsychiatric disorders. Front Neurosci, 9, 2015, 194.
43. Bruce-Keller, A.J., Fernandez-Kim, S.O., Townsend, R.L., Kruger, C., Carmouche, R., Newman, S., et al. Maternal obese-type gut microbiota differentially impact cognition, anxiety and compulsive behavior in male and female offspring in mice. PLoS One, 12, 2017, e0175577.
44. Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
45. Jašarević E., Howerton, C.L., Howard, C.D., Bale, T.L., Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 156 (2015), 3265–3276.
46. Jašarević E., Howard, C.D., Misic, A.M., Beiting, D.P., Bale, T.L., Stress during pregnancy alters temporal and spatial dynamics of the maternal and offspring microbiome in a sex-specific manner. Sci Rep, 7, 2017, 44182.
47. Lyall, K., Munger, K.L., O'Reilly, É.J., Santangelo, S.L., Ascherio, A., Maternal dietary fat intake in association with autism spectrum disorders. Am J Epidemiol 178 (2013), 209–220.
48. Sullivan, E.L., Nousen, E.K., Chamlou, K.A., Maternal high fat diet consumption during the perinatal period programs offspring behavior. Physiol Behav 123 (2014), 236–242.
49. Buffington, S.A., Di Prisco, G.V., Auchtung, T.A., Ajami, N.J., Petrosino, J.F., Costa-Mattioli, M., Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell Host Microbe 165 (2016), 1762–1775.
50. Stinson, L.F., Payne, M.S., Keelan, J.A., Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit Rev Microbiol 43 (2017), 352–369.
51. Garcia-Mantrana, I., Collado, M.C., Obesity and overweight: Impact on maternal and milk microbiome and their role for infant health and nutrition. Mol Nutr Food Res 60 (2016), 1865–1875.
52. Berthoud, H.R., Kressel, M., Raybould, H.E., Neuhuber, W.L., Vagal sensors in the rat duodenal mucosa: Distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol (Berl) 191 (1995), 203–212.
53. Berthoud, H.R., Blackshaw, L.A., Brookes, S.J., Grundy, D., Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract. Neurogastroenterol Motil 16:Suppl 1 (2004), 28–33.
54. Patterson, E., Cryan, J.F., Fitzgerald, G.F., Ross, R.P., Dinan, T.G., Stanton, C., Gut microbiota, the pharmabiotics they produce and host health. Proc Nutr Soc 73 (2014), 477–489.
55. Perez-Burgos, A., Wang, B., Mao, Y.K., Mistry, B., McVey Neufeld, K.A., Bienenstock, J., et al. Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents. Am J Physiol Gastrointest Liver Physiol 304 (2013), G211–G220.
56. de Jonge, W.J., van der Zanden, E.P., The, F.O., Bijlsma, M.F., van Westerloo, D.J., Bennink, R.J., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 (2005), 844–851.
57. Matteoli, G., Boeckxstaens, G.E., The vagal innervation of the gut and immune homeostasis. Gut 62 (2013), 1214–1222.
58. Schwartz, G.J., Salorio, C.F., Skoglund, C., Moran, T.H., Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression. Am J Physiol 276 (1999), R1623–R1629.
59. Klarer, M., Arnold, M., Gunther, L., Winter, C., Langhans, W., Meyer, U., Gut vagal afferents differentially modulate innate anxiety and learned fear. J Neurosci 34 (2014), 7067–7076.
60. de Lartigue, G., Ronveaux, C.C., Raybould, H.E., Deletion of leptin signaling in vagal afferent neurons results in hyperphagia and obesity. Mol Metab 3 (2014), 595–607.
61. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277 (2015), 32–48.
62. Williams, B.B., Van Benschoten, A.H., Cimermancic, P., Donia, M.S., Zimmermann, M., Taketani, M., et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe 16 (2014), 495–503.
63. Wall, R., Cryan, J.F., Ross, R.P., Fitzgerald, G.F., Dinan, T.G., Stanton, C., Bacterial neuroactive compounds produced by psychobiotics. Adv Exp Med Biol 817 (2014), 221–223.
64. Barrett, E., Ross, R.P., O'Toole, P.W., Fitzgerald, G.F., Stanton, C., γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 113 (2012), 411–417.
65. Lyte, M., Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics. Bioessays 33 (2011), 574–581.
66. Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 18 (2013), 666–673.
67. Chakraborti, C.K., New-found link between microbiota and obesity. World J Gastrointest Pathophysiol 6 (2015), 110–119.
68. Roediger, W.E., Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83 (1982), 424–429.
69. Bergman, E.N., Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70 (1990), 567–590.
70. Sivaprakasam, S., Prasad, P.D., Singh, N., Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 164 (2016), 144–151.
71. Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 108 (2011), 8030–8035.
72. Nøhr, M.K., Pedersen, M.H., Gille, A., Egerod, K.L., Engelstoft, M.S., Husted, A.S., et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154 (2013), 3552–3564.
73. Al-Asmakh, M., Hedin, L., Microbiota and the control of blood-tissue barriers. Tissue Barriers, 3, 2015, e1039691.
74. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med, 263, 2014, 263ra158.
75. Erny, D., Hrabě de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18 (2015), 965–977.
76. Laurent, R.S., O'Brien, L.M., Ahmad, S.T., Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease. Neuroscience 246 (2013), 382–390.
77. Ferrante, R.J., Kubilus, J.K., Lee, J., Ryu, H., Beesen, A., Zucker, B., et al. Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23 (2003), 9418–9427.
78. Sampson, T., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell 167 (2016), 1469–1480.
79. MacFabe, D.F., Enteric short-chain fatty acids: Microbial messengers of metabolism, mitochondria, and mind: Implications in autism spectrum disorders. Microb Ecol Health Dis, 26, 2015, 28177.
80. Foley, K.A., Ossenkopp, K.P., Kavaliers, M., Macfabe, D.F., Pre- and neonatal exposure to lipopolysaccharide or the enteric metabolite, propionic acid, alters development and behavior in adolescent rats in a sexually dimorphic manner. PLoS One, 9, 2014, e87072.
81. Shultz, S.R., Aziz, N.A., Yang, L., Sun, M., MacFabe, D.F., O'Brien, T.J., Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats. Behav Brain Res 278 (2015), 542–548.
82. Pournaras, D.J., le Roux, C.W., Are bile acids the new gut hormones? Lessons from weight loss surgery models. Endocrinology 154 (2013), 2255–2256.
83. Wahlstrom, A., Sayin, S.I., Marschall, H.U., Backhed, F., Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab 24 (2016), 41–50.
84. Joyce, S.A., MacSharry, J., Casey, P.G., Kinsella, M., Murphy, E.F., Shanahan, F., et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A 111 (2014), 7421–7426.
85. Joyce, S.A., Gahan, C.G., Disease-associated changes in bile acid profiles and links to altered gut microbiota. Dig Dis 35 (2017), 169–177.
86. Dionísio, P.A., Amaral, J.D., Ribeiro, M.F., Lo, A.C., D'Hooge, R., Rodrigues, C.M., Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Neurobiol Aging 36 (2015), 228–240.
87. Moreira, S., Fonseca, I., Nunes, M.J., Rosa, A., Lemos, L., Rodrigues, E., et al. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease. Exp Neurol 295 (2017), 77–87.
88. Govindarajan, K., MacSharry, J., Casey, P.G., Shanahan, F., Joyce, S.A., Gahan, C.G., Unconjugated bile acids influence expression of circadian genes: A potential mechanism for microbe-host crosstalk. PLoS One, 11, 2016, e0167319.
89. Pan, X., Elliott, C.T., McGuinness, B., Passmore, P., Kehoe, P.G., Hölscher, C., et al. Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer's disease. Metabolites, 7(2), 2017.
90. Raison, C.L., Miller, A.H., Is depression an inflammatory disorder?. Curr Psychiatry Rep 13 (2011), 467–475.
91. Lyman, M., Lloyd, D.G., Ji, X., Vizcaychipi, M.P., Neuroinflammation: The role and consequences. Neurosci Res 79C (2014), 1–12.
92. Mielcarz, D.W., Kasper, L.H., The gut microbiome in multiple sclerosis. Curr Treat Options Neurol, 17, 2015, 344.
93. Tomkovich, S., Jobin, C., Microbiota and host immune responses: A love-hate relationship. Immunology 147 (2016), 1–10.
94. Fung, T.C., Olson, C.A., Hsiao, E.Y., Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20 (2017), 145–155.
95. Kamada, N., Seo, S.U., Chen, G.Y., Nunez, G., Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13 (2013), 321–335.
96. Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479 (2011), 538–541.
97. Okada, Y., Tsuzuki, Y., Sato, H., Narimatsu, K., Hokari, R., Kurihara, C., et al. Trans fatty acids exacerbate dextran sodium sulphate-induced colitis by promoting the up-regulation of macrophage-derived proinflammatory cytokines involved in T helper 17 cell polarization. Clin Exp Immunol 174 (2013), 459–471.
98. Deopurkar, R., Ghanim, H., Friedman, J., Abuaysheh, S., Sia, C.L., Mohanty, P., et al. Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33 (2010), 991–997.
99. Lupp, C., Robertson, M.L., Wickham, M.E., Sekirov, I., Champion, O.L., Gaynor, E.C., et al. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2 (2007), 119–129.
100. Stecher, B., Robbiani, R., Walker, A.W., Westendorf, A.M., Barthel, M., Kremer, M., et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5 (2007), 2177–2189.
101. Pédron, T., Sansonetti, P., Commensals, bacterial pathogens and intestinal inflammation: An intriguing ménage à trois. Cell Host Microbe 3 (2008), 344–347.
102. Munford, R.S., Varley, A.W., Shield as signal: Lipopolysaccharides and the evolution of immunity to gram-negative bacteria. PLoS Pathog, 2, 2006, e67.
103. Hooper, L.V., Gordon, J.I., Commensal host-bacterial relationships in the gut. Science 292 (2001), 1115–1118.
104. Moreira, A.P., Texeira, T.F., Ferreira, A.B., Peluzio, C., Alfenas, R., Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 108 (2012), 801–809.
105. de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C., Raybould, H.E., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299 (2010), G440–G448.
106. Cani, P.D., Bibiloni, B., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes Care 57 (2008), 1470–1481.
107. Etxeberria, U., Arias, N., Boqué N., Macarulla, M.T., Portillo, M.P., Milagro, F.I., et al. Shifts in microbiota species and fermentation products in a dietary model enriched in fat and sucrose. Benef Microbes 6 (2015), 97–111.
108. Martinez-Medina, M., Denizot, J., Dreux, N., Robin, F., Billard, E., Bonnet, R., et al. Western diet induces dysbiosis with increased E coli in CEABAC10 mice, alters host barrier function favouring AIEC colonisation. Gut 63 (2014), 116–124.
109. Piya, M.K., Harte, A.L., McTernan, P.G., Metabolic endotoxaemia: Is it more than just a gut feeling?. Curr Opin Lipidol 24 (2013), 78–85.
110. Spor, A., Koren, O., Ley, R., Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9 (2011), 279–290.
111. Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
112. Garrett, W.S., Lord, G.M., Punit, S., Lugo-Villarino, G., Mazmanian, S.K., Ito, S., et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131 (2007), 33–45.
113. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455 (2008), 1109–1113.
114. David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
115. Turnbaugh, P.J., Ridaura, V.K., Faith, J.J., Rey, F.E., Knight, R., Gordon, J.I., The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med, 1, 2009, 6ra14.
116. Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334 (2011), 105–108.
117. Fava, F., Gitau, R., Griffin, B.A., Gibson, G.R., Tuohy, K.M., Lovegrove, J.A., The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome “at-risk” population. Int J Obes (Lond) 37 (2013), 216–223.
118. Schnorr, S.L., The diverse microbiome of the hunter-gatherer. Nature 518 (2015), S14–S15.
119. Martinez, I., Stegen, J.C., Maldonado-Gomez, M.X., Eren, A.M., Siba, P.M., Greenhill, A.R., et al. The gut microbiota of rural papua new guineans: Composition, diversity patterns, and ecological processes. Cell Rep 11 (2015), 527–538.
120. Clemente, J.C., Pehrsson, E.C., Blaser, M.J., Sandhu, K., Gao, Z., Wang, B., et al. The microbiome of uncontacted Amerindians. Sci Adv, 1(3), 2015.
121. Simpson, H.L., Campbell, B.J., Review article: Dietary fibre-microbiota interactions. Aliment Pharmacol Ther 42 (2015), 158–179.
122. Sonnenburg, E.D., Smits, S.A., Tikhonov, M., Higginbottom, S.K., Wingreen, N.S., Sonnenburg, J.L., Diet-induced extinctions in the gut microbiota compound over generations. Nature 529 (2016), 212–215.
123. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
124. Cotillard, A., Kennedy, S.P., Kong, L.C., Prifti, E., Pons, N., Le Chatelier, E., et al. Dietary intervention impact on gut microbial gene richness. Nature 500 (2013), 585–588.
125. Dawson, S.L., Dash, S.R., Jacka, F.N., The importance of diet and gut health to the treatment and prevention of mental disorders. Int Rev Neurobiol 131 (2016), 325–346.
126. Rienks, J., Dobson, A.J., Mishra, G.D., Mediterranean dietary pattern and prevalence and incidence of depressive symptoms in mid-aged women: Results from a large community-based prospective study. Eur J Clin Nutr 67 (2013), 75–82.
127. Flórez, K.R., Dubowitz, T., Ghosh-Dastidar, M.B., Beckman, R., Collins, R.L., Associations between depressive symptomatology, diet, and body mass index among participants in the supplemental nutrition assistance program. J Acad Nutr Diet 115 (2015), 1102–1108.
128. Huddy, R.L., Torres, S.J., Milte, C.M., McNaughton, S.A., Teychenne, M., Campbell, K.J., Higher adherence to the Australian Dietary Guidelines is associated with better mental health status among Australian adult first-time mothers. J Acad Nutr Diet 116 (2016), 1406–1412.
129. Mihrshahi, S., Dobson, A.J., Mishra, G.D., Fruit and vegetable consumption and prevalence and incidence of depressive symptoms in mid-age women: Results from the Australian longitudinal study on women's health. Eur J Clin Nutr 69 (2015), 585–591.
130. Lai, J.S., Oldmeadow, C., Hure, A.J., McEvoy, M., Byles, J., Attia, J., Longitudinal diet quality is not associated with depressive symptoms in a cohort of middle-aged Australian women. Br J Nutr 115 (2016), 842–850.
131. Martínez-González, M.A., Sánchez-Villegas, A., Food patterns and the prevention of depression. Proc Nutr Soc 75 (2016), 139–146.
132. Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: A novel class of psychotropic. Biol Psychiatry 74 (2013), 720–726.
133. Sarkar, A., Lehto, S.M., Harty, S., Dinan, T.G., Cryan, J.F., Burnet, P.W., Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci 39 (2016), 763–781.
134. Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144 (2013), 1394–1401 1401e1–1401e4.
135. Messaoudi, M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105 (2011), 755–764.
136. Steenbergen, L., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48 (2015), 258–264.
137. Labus, J.S., Hollister, E.B., Jacobs, J., Kirbach, K., Oezguen, N., Gupta, A., et al. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome, 5, 2017, 49.
138. Pinto-Sanchez, M.I., Hall, G.B., Ghajar, K., Nardelli, A., Bolino, C., Lau, J.T., et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity: A pilot study in patients with irritable bowel syndrome. Gastroenterology 153 (2017), 448–459.e8.
139. Kato-Kataoka, A., Fermented milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Appl Environ Microbiol 82 (2016), 3649–3658.
140. Kelly, J.R., Allen, A.P., Temko, A., Hutch, W., Kennedy, P.J., Farid, N., et al. Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun 61 (2017), 50–59.
141. Mattia, A., Merker, R., Regulation of probiotic substances as ingredients in foods: Premarket approval or “generally recognized as safe” notification. Clin Infect Dis 46:Suppl 2 (2008), S115–S118.
142. Doron, S., Snydman, D.R., Risk and safety of probiotics. Clin Infect Dis 60:Suppl 2 (2015), S129–S134.
143. Wallace, C.J.K., Milev, R., The effects of probiotics on depressive symptoms in humans: A systematic review. Ann Gen Psychiatry, 16, 2017, 14.
144. Burokas, A., Arboleya, S., Moloney, R.D., Peterson, V.L., Murphy, K., Clarke, G., et al. Targeting the microbiota-gut-brain axis: Prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry 82 (2017), 472–487.
145. Mika, A., Day, H.E., Martinez, A., Rumian, N.L., Greenwood, B.N., Chichlowski, M., et al. Early life diets with prebiotics and bioactive milk fractions attenuate the impact of stress on learned helplessness behaviours and alter gene expression within neural circuits important for stress resistance. Eur J Neurosci 45 (2017), 342–357.
146. Schmidt, K., Cowen, P.J., Harmer, C.J., Tzortzis, G., Errington, S., Burnet, P.W., Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology (Berl) 232 (2015), 1793–1801.
147. Gough, E., Shaikh, H., Manges, A.R., Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53 (2011), 994–1002.
148. Borody, T.J., Peattie, D., Mitchell, S.W., Fecal microbiota transplantation: Expanding horizons for Clostridium difficile infections and beyond. Antibiotics (Basel) 4 (2015), 254–266.
149. Vindigni, S.M., Surawicz, C.M., Fecal microbiota transplantation. Gastroenterol Clin North Am 46 (2017), 171–185.
150. Anderson, J.L., Edney, R.J., Whelan, K., Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 36 (2012), 503–516.
151. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R.S., Bartelsman, J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.
152. Su, A., Gandhy, R., Barlow, C., Triadafilopoulos, G., A practical review of gastrointestinal manifestations in Parkinson's disease. Parkinsonism Relat Disord 39 (2017), 17–26.
153. Adams, J.B., Johansen, L.J., Powell, L.D., Quig, D., Rubin, R.A., Gastrointestinal flora and gastrointestinal status in children with autism—comparisons to typical children and correlation with autism severity. BMC Gastroenterol, 11, 2011, 22.
154. Kelly, J.R., Borre, Y., O'Brien, C., Patterson, E., El Aidy, S., Deane, J., et al. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82 (2016), 109–118.
155. Kang, D.W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome, 5, 2017, 10.
156. Claesson, M.J., Jeffery, I.B., Conde, S., Power, S.E., O'Connor, E.M., Cusack, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
157. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
158. Raoult, D., Henrissat, B., Are stool samples suitable for studying the link between gut microbiota and obesity?. Eur J Epidemiol 29 (2014), 307–309.
159. Rozee, K.R., Cooper, D., Lam, K., Costerton, J.W., Microbial flora of the mouse ileum mucous layer and epithelial surface. Appl Environ Microbiol 43 (1982), 1451–1463.
160. Faderl, M., Noti, M., Corazza, N., Mueller, C., Keeping bugs in check: The mucus layer as a critical component in maintaining intestinal homeostasis. IUBMB Life 67 (2015), 275–285.
161. Johansson, M.E., Larsson, J.M., Hansson, G.C., The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108:Suppl 1 (2011), 4659–4665.
162. Gu, S., Chen, D., Zhang, J.N., Lv, X., Wang, K., Duan, L.P., et al. Bacterial community mapping of the mouse gastrointestinal tract. PLoS One, 8, 2013, e74957.
163. Claus, S.P., Tsang, T.M., Wang, Y., Cloarec, O., Skordi, E., Martin, F.P., et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol Syst Biol, 4, 2008, 219.
164. Wirth, R., Bodi, N., Maroti, G., Bagyanszki, M., Talapka, P., Fekete, E., et al. Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One, 9, 2014, e110440.
165. Lu, H.P., Lai, Y.C., Huang, S.W., Chen, H.C., Hsieh, C.H., Yu, H.T., Spatial heterogeneity of gut microbiota reveals multiple bacterial communities with distinct characteristics. Sci Rep, 4, 2014, 6185.
166. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.